182 related articles for article (PubMed ID: 37902189)
21. Detection of complex chromosome rearrangements using optical genome mapping.
Qu J; Li S; Yu D
Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis.
Yen CC; Chen YJ; Chen JT; Hsia JY; Chen PM; Liu JH; Fan FS; Chiou TJ; Wang WS; Lin CH
Cancer; 2001 Dec; 92(11):2769-77. PubMed ID: 11753950
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic studies in prostate cancer: are we making progress?
Brothman AR
Cancer Genet Cytogenet; 1997 May; 95(1):116-21. PubMed ID: 9140461
[TBL] [Abstract][Full Text] [Related]
24. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
25. [Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping].
Wang YF; Zhang ZH; Wang H; Xi LY; Dong F; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):303-307. PubMed ID: 38716605
[TBL] [Abstract][Full Text] [Related]
26. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
Heim S; Mandahl N; Arheden K; Giovanella BC; Yim SO; Stehlin JS; Mitelman F
Cancer Genet Cytogenet; 1988 Oct; 35(1):5-20. PubMed ID: 3180009
[TBL] [Abstract][Full Text] [Related]
27. Combination of trio-based whole exome sequencing and optical genome mapping reveals a cryptic balanced translocation that causes unbalanced chromosomal rearrangements in a family with multiple anomalies.
Xie M; Xue J; Zhang Y; Zhou Y; Yu Q; Li H; Li Q
Front Genet; 2023; 14():1248544. PubMed ID: 37745854
[No Abstract] [Full Text] [Related]
28. Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping.
Sirivatanauksorn V; Sirivatanauksorn Y; Gorman PA; Davidson JM; Sheer D; Moore PS; Scarpa A; Edwards PA; Lemoine NR
Int J Cancer; 2001 Feb; 91(3):350-8. PubMed ID: 11169959
[TBL] [Abstract][Full Text] [Related]
29. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract][Full Text] [Related]
31. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.
Parada LA; Marañon A; Hallén M; Tranberg KG; Stenram U; Bardi G; Johansson B
Clin Exp Metastasis; 1999; 17(6):471-9. PubMed ID: 10763912
[TBL] [Abstract][Full Text] [Related]
33. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
[TBL] [Abstract][Full Text] [Related]
34. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
35. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
36. Identification of genetic markers for prostatic cancer progression.
Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
[TBL] [Abstract][Full Text] [Related]
37. Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
Iriondo J; Gómez A; Zubicaray J; Garcia-Martinez J; Abad L; Matesanz C; Giménez R; Galán A; Sanz A; Sebastián E; González de Pablo J; de la Cruz A; Ramírez M; Sevilla J
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790188
[TBL] [Abstract][Full Text] [Related]
38. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
[TBL] [Abstract][Full Text] [Related]
40. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
